Purchase Order 75N92E23P00046
- Not listed
- This is a $37,814 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. The contract is for the extraction of total RNA from whole blood samples in support of research activities at the National Human Genome Research Institute (NHGRI), another NIH agency. The contract was awarded on July 10, 2020 through full and open competition, with a period of performance ending on March 31,...
- This federal contract was awarded by a U.S. government agency to Reprocell U.S.A., Inc., a for-profit organization that specializes in providing biological materials and related services to support biomedical research. The contract is for DNA sample analysis, with a firm fixed price of $73,647.00 and a completion date of April 30, 2008. The work is being performed in Laurel, Maryland and was awarded on May 1, 2007 without any set-aside designation. Reprocell U.S.A., Inc. has primarily worked...
- The federal contract award 75N95D24P00067 was made by the National Institute on Aging (NIA), a civilian agency within the U.S. government, to Reprocell U.S.A., Inc., a for-profit organization, for laboratory testing services related to RNA and DNA extraction from mouse and human models. The $20,902.50 firm fixed price contract has a period of performance through July 30, 2024. The contract was awarded under full and open competition with no set-aside designation. Reprocell U.S.A., Inc. has...
- The National Institute of Environmental Health Sciences awarded a $7,530 firm fixed-price BPA call contract to Reprocell U.S.A., Inc. on May 21, 2014, with completion targeted for June 30, 2014. The contract covers genotyping analysis services utilizing Reprocell's catalog items BIO1020 and BIO1030, with work to be performed in Calverton, Maryland. This award was not designated as a set-aside contract and was procured through the company's existing blanket purchase agreement vehicle with the...
- On September 15, 2016, the National Institute of Environmental Health Sciences awarded a firm fixed-price Blanket Purchase Agreement (BPA) call to Reprocell U.S.A., Inc. valued at $14,860. The contract, which was awarded without set-aside designation through full and open competition, was performed in Calverton, Maryland, with an ultimate completion date of June 30, 2017. Reprocell U.S.A., Inc., a for-profit biotechnology services provider registered in SAM.gov since 2001, specializes in...
- <p>This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Invivogen, a for-profit organization, for the delivery of biological and reagent materials. The contract has a ceiling value of $12,992.70 and a period of performance ending on March 3, 2026. This contract is not associated with a larger vehicle and does not have a set-aside designation. The NHGRI is the funding agency for this contract.</p>
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to SBH Sciences Inc. on June 12, 2018. The contract has a ceiling value of $8,300 and an ultimate completion date of August 31, 2020. The contract is not designated as a set-aside. Based on the information provided, this award appears to be for a specific product or service required by NHGRI, which is the lead National Institutes of Health (NIH) institute responsible...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract was awarded to 10X Genomics, Inc., a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The purpose of this $15,550.20 contract is to provide 10X Genomics optimization...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services National Institutes of Health National Human Genome Research Institute to the non-profit Wicell Research Institute, Inc. for services related to the karyotype analysis and fluorescence in situ hybridization (FISH) testing of human cell lines. The $17,178.50 contract is for the delivery of these specific testing and analysis services on human pluripotent stem cell lines to support biomedical research...
- The National Human Genome Research Institute (NHGRI) has awarded a $198,082.98 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for Revio Single Molecule Real-Time (SMRT) cells and sequencing reagents. This new award, announced on September 16, 2025, with an ultimate completion date of September 26, 2026, represents a direct procurement of specialized laboratory consumables essential for advanced genomic sequencing operations. The contract carries no set-aside...
This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. for $17,016.80. The contract was awarded on January 5, 2023 with a completion date of July 5, 2023. The contract supports genetic and epigenetic analysis at the transcriptome level, which is a critical component of the Comprehensive Disease Study (CDS) program's integrative research approach. Reprocell U.S.A., Inc. is a for-profit organization specializing in advanced biological research services such as laboratory testing and material extraction. The contract was awarded through full and open competition with no set-aside designation, indicating Reprocell's competitive position in providing specialized scientific support to federal research institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 12/27/22 |